• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Pharmaceutical CDMO Services Market Size, Status and Forecast 2020-2026

report cover
  • 22 June 2020
  • Pharmaceuticals
  • 95 Pages
  • Report Code: 24LS-8609
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Pharmaceutical CDMO Services -MARKET ADVISORY SERVICES

This report focuses on the global Pharmaceutical CDMO Services status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical CDMO Services development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.


The key players covered in this study

  • Recipharm AB
  • AMRI Global
  • Patheon N.V.
  • Aenova Group
  • Catalent, Inc.
  • Amatsigroup
  • WuXi AppTec Group
  • Strides Pharma Science Limited
  • Piramal Pharma Solutions
  • Siegfried Ltd
  • Fareva Group
  • FAMAR Health Care Services


Market segment by Type, the product can be split into

  • Drug Substance Development and Manufacturing
  • Specialized Services
  • Lab-based Services

Market segment by Application, split into

  • Innovative Medicine
  • Patented Drug
  • Patent Expired Drug


Market segment by Regions/Countries, this report covers

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America


The study objectives of this report are:

  • To analyze global Pharmaceutical CDMO Services status, future forecast, growth opportunity, key market and key players.
  • To present the Pharmaceutical CDMO Services development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.


In this study, the years considered to estimate the market size of Pharmaceutical CDMO Services are as follows:

  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceutical CDMO Services Revenue
1.4 Market Analysis by Type
1.4.1 Global Pharmaceutical CDMO Services Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drug Substance Development and Manufacturing
1.4.3 Specialized Services
1.4.4 Lab-based Services
1.5 Market by Application
1.5.1 Global Pharmaceutical CDMO Services Market Share by Application: 2020 VS 2026
1.5.2 Innovative Medicine
1.5.3 Patented Drug
1.5.4 Patent Expired Drug
1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceutical CDMO Services Industry Impact
1.6.1 How the Covid-19 is Affecting the Pharmaceutical CDMO Services Industry
1.6.1.1 Pharmaceutical CDMO Services Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pharmaceutical CDMO Services Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pharmaceutical CDMO Services Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Pharmaceutical CDMO Services Market Perspective (2015-2026)
2.2 Pharmaceutical CDMO Services Growth Trends by Regions
2.2.1 Pharmaceutical CDMO Services Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmaceutical CDMO Services Historic Market Share by Regions (2015-2020)
2.2.3 Pharmaceutical CDMO Services Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pharmaceutical CDMO Services Market Growth Strategy
2.3.6 Primary Interviews with Key Pharmaceutical CDMO Services Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical CDMO Services Players by Market Size
3.1.1 Global Top Pharmaceutical CDMO Services Players by Revenue (2015-2020)
3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by Players (2015-2020)
3.1.3 Global Pharmaceutical CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmaceutical CDMO Services Market Concentration Ratio
3.2.1 Global Pharmaceutical CDMO Services Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO Services Revenue in 2019
3.3 Pharmaceutical CDMO Services Key Players Head office and Area Served
3.4 Key Players Pharmaceutical CDMO Services Product Solution and Service
3.5 Date of Enter into Pharmaceutical CDMO Services Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Pharmaceutical CDMO Services Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Type (2021-2026)

5 Pharmaceutical CDMO Services Breakdown Data by Application (2015-2026)
5.1 Global Pharmaceutical CDMO Services Market Size by Application (2015-2020)
5.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Pharmaceutical CDMO Services Market Size (2015-2020)
6.2 Pharmaceutical CDMO Services Key Players in North America (2019-2020)
6.3 North America Pharmaceutical CDMO Services Market Size by Type (2015-2020)
6.4 North America Pharmaceutical CDMO Services Market Size by Application (2015-2020)

7 Europe
7.1 Europe Pharmaceutical CDMO Services Market Size (2015-2020)
7.2 Pharmaceutical CDMO Services Key Players in Europe (2019-2020)
7.3 Europe Pharmaceutical CDMO Services Market Size by Type (2015-2020)
7.4 Europe Pharmaceutical CDMO Services Market Size by Application (2015-2020)

8 China
8.1 China Pharmaceutical CDMO Services Market Size (2015-2020)
8.2 Pharmaceutical CDMO Services Key Players in China (2019-2020)
8.3 China Pharmaceutical CDMO Services Market Size by Type (2015-2020)
8.4 China Pharmaceutical CDMO Services Market Size by Application (2015-2020)

9 Japan
9.1 Japan Pharmaceutical CDMO Services Market Size (2015-2020)
9.2 Pharmaceutical CDMO Services Key Players in Japan (2019-2020)
9.3 Japan Pharmaceutical CDMO Services Market Size by Type (2015-2020)
9.4 Japan Pharmaceutical CDMO Services Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Pharmaceutical CDMO Services Market Size (2015-2020)
10.2 Pharmaceutical CDMO Services Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmaceutical CDMO Services Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmaceutical CDMO Services Market Size by Application (2015-2020)

11 India
11.1 India Pharmaceutical CDMO Services Market Size (2015-2020)
11.2 Pharmaceutical CDMO Services Key Players in India (2019-2020)
11.3 India Pharmaceutical CDMO Services Market Size by Type (2015-2020)
11.4 India Pharmaceutical CDMO Services Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Pharmaceutical CDMO Services Market Size (2015-2020)
12.2 Pharmaceutical CDMO Services Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmaceutical CDMO Services Market Size by Type (2015-2020)
12.4 Central & South America Pharmaceutical CDMO Services Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Recipharm AB
13.1.1 Recipharm AB Company Details
13.1.2 Recipharm AB Business Overview and Its Total Revenue
13.1.3 Recipharm AB Pharmaceutical CDMO Services Introduction
13.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2015-2020))
13.1.5 Recipharm AB Recent Development
13.2 AMRI Global
13.2.1 AMRI Global Company Details
13.2.2 AMRI Global Business Overview and Its Total Revenue
13.2.3 AMRI Global Pharmaceutical CDMO Services Introduction
13.2.4 AMRI Global Revenue in Pharmaceutical CDMO Services Business (2015-2020)
13.2.5 AMRI Global Recent Development
13.3 Patheon N.V.
13.3.1 Patheon N.V. Company Details
13.3.2 Patheon N.V. Business Overview and Its Total Revenue
13.3.3 Patheon N.V. Pharmaceutical CDMO Services Introduction
13.3.4 Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2015-2020)
13.3.5 Patheon N.V. Recent Development
13.4 Aenova Group
13.4.1 Aenova Group Company Details
13.4.2 Aenova Group Business Overview and Its Total Revenue
13.4.3 Aenova Group Pharmaceutical CDMO Services Introduction
13.4.4 Aenova Group Revenue in Pharmaceutical CDMO Services Business (2015-2020)
13.4.5 Aenova Group Recent Development
13.5 Catalent, Inc.
13.5.1 Catalent, Inc. Company Details
13.5.2 Catalent, Inc. Business Overview and Its Total Revenue
13.5.3 Catalent, Inc. Pharmaceutical CDMO Services Introduction
13.5.4 Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2015-2020)
13.5.5 Catalent, Inc. Recent Development
13.6 Amatsigroup
13.6.1 Amatsigroup Company Details
13.6.2 Amatsigroup Business Overview and Its Total Revenue
13.6.3 Amatsigroup Pharmaceutical CDMO Services Introduction
13.6.4 Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2015-2020)
13.6.5 Amatsigroup Recent Development
13.7 WuXi AppTec Group
13.7.1 WuXi AppTec Group Company Details
13.7.2 WuXi AppTec Group Business Overview and Its Total Revenue
13.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Introduction
13.7.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2015-2020)
13.7.5 WuXi AppTec Group Recent Development
13.8 Strides Pharma Science Limited
13.8.1 Strides Pharma Science Limited Company Details
13.8.2 Strides Pharma Science Limited Business Overview and Its Total Revenue
13.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Introduction
13.8.4 Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2015-2020)
13.8.5 Strides Pharma Science Limited Recent Development
13.9 Piramal Pharma Solutions
13.9.1 Piramal Pharma Solutions Company Details
13.9.2 Piramal Pharma Solutions Business Overview and Its Total Revenue
13.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Introduction
13.9.4 Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2015-2020)
13.9.5 Piramal Pharma Solutions Recent Development
13.10 Siegfried Ltd
13.10.1 Siegfried Ltd Company Details
13.10.2 Siegfried Ltd Business Overview and Its Total Revenue
13.10.3 Siegfried Ltd Pharmaceutical CDMO Services Introduction
13.10.4 Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2015-2020)
13.10.5 Siegfried Ltd Recent Development
13.11 Fareva Group
10.11.1 Fareva Group Company Details
10.11.2 Fareva Group Business Overview and Its Total Revenue
10.11.3 Fareva Group Pharmaceutical CDMO Services Introduction
10.11.4 Fareva Group Revenue in Pharmaceutical CDMO Services Business (2015-2020)
10.11.5 Fareva Group Recent Development
13.12 FAMAR Health Care Services
10.12.1 FAMAR Health Care Services Company Details
10.12.2 FAMAR Health Care Services Business Overview and Its Total Revenue
10.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Introduction
10.12.4 FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2015-2020)
10.12.5 FAMAR Health Care Services Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Pharmaceutical CDMO Services Key Market Segments

Table 2. Key Players Covered: Ranking by Pharmaceutical CDMO Services Revenue

Table 3. Ranking of Global Top Pharmaceutical CDMO Services Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Pharmaceutical CDMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Drug Substance Development and Manufacturing

Table 6. Key Players of Specialized Services

Table 7. Key Players of Lab-based Services

Table 8. COVID-19 Impact Global Market: (Four Pharmaceutical CDMO Services Market Size Forecast Scenarios)

Table 9. Opportunities and Trends for Pharmaceutical CDMO Services Players in the COVID-19 Landscape

Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 11. Key Regions/Countries Measures against Covid-19 Impact

Table 12. Proposal for Pharmaceutical CDMO Services Players to Combat Covid-19 Impact

Table 13. Global Pharmaceutical CDMO Services Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 14. Global Pharmaceutical CDMO Services Market Size by Regions (US$ Million): 2020 VS 2026

Table 15. Global Pharmaceutical CDMO Services Market Size by Regions (2015-2020) (US$ Million)

Table 16. Global Pharmaceutical CDMO Services Market Share by Regions (2015-2020)

Table 17. Global Pharmaceutical CDMO Services Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 18. Global Pharmaceutical CDMO Services Market Share by Regions (2021-2026)

Table 19. Market Top Trends

Table 20. Key Drivers: Impact Analysis

Table 21. Key Challenges

Table 22. Pharmaceutical CDMO Services Market Growth Strategy

Table 23. Main Points Interviewed from Key Pharmaceutical CDMO Services Players

Table 24. Global Pharmaceutical CDMO Services Revenue by Players (2015-2020) (Million US$)

Table 25. Global Pharmaceutical CDMO Services Market Share by Players (2015-2020)

Table 26. Global Top Pharmaceutical CDMO Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical CDMO Services as of 2019)

Table 27. Global Pharmaceutical CDMO Services by Players Market Concentration Ratio (CR5 and HHI)

Table 28. Key Players Headquarters and Area Served

Table 29. Key Players Pharmaceutical CDMO Services Product Solution and Service

Table 30. Date of Enter into Pharmaceutical CDMO Services Market

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Pharmaceutical CDMO Services Market Size by Type (2015-2020) (Million US$)

Table 33. Global Pharmaceutical CDMO Services Market Size Share by Type (2015-2020)

Table 34. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2021-2026)

Table 35. Global Pharmaceutical CDMO Services Market Size Share by Application (2015-2020)

Table 36. Global Pharmaceutical CDMO Services Market Size by Application (2015-2020) (Million US$)

Table 37. Global Pharmaceutical CDMO Services Market Size Share by Application (2021-2026)

Table 38. North America Key Players Pharmaceutical CDMO Services Revenue (2019-2020) (Million US$)

Table 39. North America Key Players Pharmaceutical CDMO Services Market Share (2019-2020)

Table 40. North America Pharmaceutical CDMO Services Market Size by Type (2015-2020) (Million US$)

Table 41. North America Pharmaceutical CDMO Services Market Share by Type (2015-2020)

Table 42. North America Pharmaceutical CDMO Services Market Size by Application (2015-2020) (Million US$)

Table 43. North America Pharmaceutical CDMO Services Market Share by Application (2015-2020)

Table 44. Europe Key Players Pharmaceutical CDMO Services Revenue (2019-2020) (Million US$)

Table 45. Europe Key Players Pharmaceutical CDMO Services Market Share (2019-2020)

Table 46. Europe Pharmaceutical CDMO Services Market Size by Type (2015-2020) (Million US$)

Table 47. Europe Pharmaceutical CDMO Services Market Share by Type (2015-2020)

Table 48. Europe Pharmaceutical CDMO Services Market Size by Application (2015-2020) (Million US$)

Table 49. Europe Pharmaceutical CDMO Services Market Share by Application (2015-2020)

Table 50. China Key Players Pharmaceutical CDMO Services Revenue (2019-2020) (Million US$)

Table 51. China Key Players Pharmaceutical CDMO Services Market Share (2019-2020)

Table 52. China Pharmaceutical CDMO Services Market Size by Type (2015-2020) (Million US$)

Table 53. China Pharmaceutical CDMO Services Market Share by Type (2015-2020)

Table 54. China Pharmaceutical CDMO Services Market Size by Application (2015-2020) (Million US$)

Table 55. China Pharmaceutical CDMO Services Market Share by Application (2015-2020)

Table 56. Japan Key Players Pharmaceutical CDMO Services Revenue (2019-2020) (Million US$)

Table 57. Japan Key Players Pharmaceutical CDMO Services Market Share (2019-2020)

Table 58. Japan Pharmaceutical CDMO Services Market Size by Type (2015-2020) (Million US$)

Table 59. Japan Pharmaceutical CDMO Services Market Share by Type (2015-2020)

Table 60. Japan Pharmaceutical CDMO Services Market Size by Application (2015-2020) (Million US$)

Table 61. Japan Pharmaceutical CDMO Services Market Share by Application (2015-2020)

Table 62. Southeast Asia Key Players Pharmaceutical CDMO Services Revenue (2019-2020) (Million US$)

Table 63. Southeast Asia Key Players Pharmaceutical CDMO Services Market Share (2019-2020)

Table 64. Southeast Asia Pharmaceutical CDMO Services Market Size by Type (2015-2020) (Million US$)

Table 65. Southeast Asia Pharmaceutical CDMO Services Market Share by Type (2015-2020)

Table 66. Southeast Asia Pharmaceutical CDMO Services Market Size by Application (2015-2020) (Million US$)

Table 67. Southeast Asia Pharmaceutical CDMO Services Market Share by Application (2015-2020)

Table 68. India Key Players Pharmaceutical CDMO Services Revenue (2019-2020) (Million US$)

Table 69. India Key Players Pharmaceutical CDMO Services Market Share (2019-2020)

Table 70. India Pharmaceutical CDMO Services Market Size by Type (2015-2020) (Million US$)

Table 71. India Pharmaceutical CDMO Services Market Share by Type (2015-2020)

Table 72. India Pharmaceutical CDMO Services Market Size by Application (2015-2020) (Million US$)

Table 73. India Pharmaceutical CDMO Services Market Share by Application (2015-2020)

Table 74. Central & South America Key Players Pharmaceutical CDMO Services Revenue (2019-2020) (Million US$)

Table 75. Central & South America Key Players Pharmaceutical CDMO Services Market Share (2019-2020)

Table 76. Central & South America Pharmaceutical CDMO Services Market Size by Type (2015-2020) (Million US$)

Table 77. Central & South America Pharmaceutical CDMO Services Market Share by Type (2015-2020)

Table 78. Central & South America Pharmaceutical CDMO Services Market Size by Application (2015-2020) (Million US$)

Table 79. Central & South America Pharmaceutical CDMO Services Market Share by Application (2015-2020)

Table 80. Recipharm AB Company Details

Table 81. Recipharm AB Business Overview

Table 82. Recipharm AB Product

Table 83. Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2015-2020) (Million US$)

Table 84. Recipharm AB Recent Development

Table 85. AMRI Global Company Details

Table 86. AMRI Global Business Overview

Table 87. AMRI Global Product

Table 88. AMRI Global Revenue in Pharmaceutical CDMO Services Business (2015-2020) (Million US$)

Table 89. AMRI Global Recent Development

Table 90. Patheon N.V. Company Details

Table 91. Patheon N.V. Business Overview

Table 92. Patheon N.V. Product

Table 93. Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2015-2020) (Million US$)

Table 94. Patheon N.V. Recent Development

Table 95. Aenova Group Company Details

Table 96. Aenova Group Business Overview

Table 97. Aenova Group Product

Table 98. Aenova Group Revenue in Pharmaceutical CDMO Services Business (2015-2020) (Million US$)

Table 99. Aenova Group Recent Development

Table 100. Catalent, Inc. Company Details

Table 101. Catalent, Inc. Business Overview

Table 102. Catalent, Inc. Product

Table 103. Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2015-2020) (Million US$)

Table 104. Catalent, Inc. Recent Development

Table 105. Amatsigroup Company Details

Table 106. Amatsigroup Business Overview

Table 107. Amatsigroup Product

Table 108. Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2015-2020) (Million US$)

Table 109. Amatsigroup Recent Development

Table 110. WuXi AppTec Group Company Details

Table 111. WuXi AppTec Group Business Overview

Table 112. WuXi AppTec Group Product

Table 113. WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2015-2020) (Million US$)

Table 114. WuXi AppTec Group Recent Development

Table 115. Strides Pharma Science Limited Business Overview

Table 116. Strides Pharma Science Limited Product

Table 117. Strides Pharma Science Limited Company Details

Table 118. Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2015-2020) (Million US$)

Table 119. Strides Pharma Science Limited Recent Development

Table 120. Piramal Pharma Solutions Company Details

Table 121. Piramal Pharma Solutions Business Overview

Table 122. Piramal Pharma Solutions Product

Table 123. Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2015-2020) (Million US$)

Table 124. Piramal Pharma Solutions Recent Development

Table 125. Siegfried Ltd Company Details

Table 126. Siegfried Ltd Business Overview

Table 127. Siegfried Ltd Product

Table 128. Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2015-2020) (Million US$)

Table 129. Siegfried Ltd Recent Development

Table 130. Fareva Group Company Details

Table 131. Fareva Group Business Overview

Table 132. Fareva Group Product

Table 133. Fareva Group Revenue in Pharmaceutical CDMO Services Business (2015-2020) (Million US$)

Table 134. Fareva Group Recent Development

Table 135. FAMAR Health Care Services Company Details

Table 136. FAMAR Health Care Services Business Overview

Table 137. FAMAR Health Care Services Product

Table 138. FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2015-2020) (Million US$)

Table 139. FAMAR Health Care Services Recent Development

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmaceutical CDMO Services Market Share by Type: 2020 VS 2026

Figure 2. Drug Substance Development and Manufacturing Features

Figure 3. Specialized Services Features

Figure 4. Lab-based Services Features

Figure 5. Global Pharmaceutical CDMO Services Market Share by Application: 2020 VS 2026

Figure 6. Innovative Medicine Case Studies

Figure 7. Patented Drug Case Studies

Figure 8. Patent Expired Drug Case Studies

Figure 9. Pharmaceutical CDMO Services Report Years Considered

Figure 10. Global Pharmaceutical CDMO Services Market Size YoY Growth 2015-2026 (US$ Million)

Figure 11. Global Pharmaceutical CDMO Services Market Share by Regions: 2020 VS 2026

Figure 12. Global Pharmaceutical CDMO Services Market Share by Regions (2021-2026)

Figure 13. Porter's Five Forces Analysis

Figure 14. Global Pharmaceutical CDMO Services Market Share by Players in 2019

Figure 15. Global Top Pharmaceutical CDMO Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical CDMO Services as of 2019

Figure 16. The Top 10 and 5 Players Market Share by Pharmaceutical CDMO Services Revenue in 2019

Figure 17. North America Pharmaceutical CDMO Services Market Size YoY Growth (2015-2020) (Million US$)

Figure 18. Europe Pharmaceutical CDMO Services Market Size YoY Growth (2015-2020) (Million US$)

Figure 19. China Pharmaceutical CDMO Services Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. Japan Pharmaceutical CDMO Services Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. Southeast Asia Pharmaceutical CDMO Services Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. India Pharmaceutical CDMO Services Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Central & South America Pharmaceutical CDMO Services Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. Recipharm AB Total Revenue (US$ Million): 2019 Compared with 2018

Figure 25. Recipharm AB Revenue Growth Rate in Pharmaceutical CDMO Services Business (2015-2020)

Figure 26. AMRI Global Total Revenue (US$ Million): 2019 Compared with 2018

Figure 27. AMRI Global Revenue Growth Rate in Pharmaceutical CDMO Services Business (2015-2020)

Figure 28. Patheon N.V. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 29. Patheon N.V. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2015-2020)

Figure 30. Aenova Group Total Revenue (US$ Million): 2019 Compared with 2018

Figure 31. Aenova Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2015-2020)

Figure 32. Catalent, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 33. Catalent, Inc. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2015-2020)

Figure 34. Amatsigroup Total Revenue (US$ Million): 2019 Compared with 2018

Figure 35. Amatsigroup Revenue Growth Rate in Pharmaceutical CDMO Services Business (2015-2020)

Figure 36. WuXi AppTec Group Total Revenue (US$ Million): 2019 Compared with 2018

Figure 37. WuXi AppTec Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2015-2020)

Figure 38. Strides Pharma Science Limited Total Revenue (US$ Million): 2019 Compared with 2018

Figure 39. Strides Pharma Science Limited Revenue Growth Rate in Pharmaceutical CDMO Services Business (2015-2020)

Figure 40. Piramal Pharma Solutions Total Revenue (US$ Million): 2019 Compared with 2018

Figure 41. Piramal Pharma Solutions Revenue Growth Rate in Pharmaceutical CDMO Services Business (2015-2020)

Figure 42. Siegfried Ltd Total Revenue (US$ Million): 2019 Compared with 2018

Figure 43. Siegfried Ltd Revenue Growth Rate in Pharmaceutical CDMO Services Business (2015-2020)

Figure 44. Fareva Group Total Revenue (US$ Million): 2019 Compared with 2018

Figure 45. Fareva Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2015-2020)

Figure 46. FAMAR Health Care Services Total Revenue (US$ Million): 2019 Compared with 2018

Figure 47. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical CDMO Services Business (2015-2020)

Figure 48. Bottom-up and Top-down Approaches for This Report

Figure 49. Data Triangulation

Figure 50. Key Executives Interviewed

Recipharm AB

AMRI Global

Patheon N.V.

Aenova Group

Catalent, Inc.

Amatsigroup

WuXi AppTec Group

Strides Pharma Science Limited

Piramal Pharma Solutions

Siegfried Ltd

Fareva Group

FAMAR Health Care Services

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3159

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase